Clinical Trials Logo

T Cell Lymphoma in Relapse clinical trials

View clinical trials related to T Cell Lymphoma in Relapse.

Filter by:
  • None
  • Page 1

NCT ID: NCT04162340 Recruiting - Clinical trials for Refractory T-Cell Lymphoma

CD4-specific CAR T Cells (CD4 CAR T Cells) for Relapsed/Refractory T Cell Malignancies

Start date: July 11, 2019
Phase: Phase 1
Study type: Interventional

This is a phase I, interventional, single arm, open label, treatment study to evaluate the safety and tolerability of CD4 CAR T cells in patients with relapsed and/or refractory T cell lymphoma.